Related Experiment Video
Updated: Feb 10, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis
Satoru Mochida1, Sarah L Maslen, Mark Skehel
1Cancer Research UK, London Research Institute, Clare Hall Laboratories, South Mimms, Herts EN6 3LD, UK.
Abstract:
Entry into mitosis in eukaryotes requires the activity of cyclin-dependent kinase 1 (Cdk1). Cdk1 is opposed by protein phosphatases in two ways: They inhibit activation of Cdk1 by dephosphorylating the protein kinases Wee1 and Myt1 and the protein phosphatase Cdc25 (key regulators of Cdk1), and they also antagonize Cdk1's own phosphorylation of downstream targets. A particular form of protein phosphatase 2A (PP2A) containing a B55δ subunit (PP2A- B55δ) is the major protein phosphatase that acts on model CDK substrates in Xenopus egg extracts and has antimitotic activity. The activity of PP2A-B55δ is high in interphase and low in mitosis, exactly opposite that of Cdk1. We report that inhibition of PP2A-B55δ results from a small protein, known as α-endosulfine (Ensa), that is phosphorylated in mitosis by the protein kinase Greatwall (Gwl). This converts Ensa into a potent and specific inhibitor of PP2A-B55δ. This pathway represents a previously unknown element in the control of mitosis.
Insights
A novel pathway inhibits protein phosphatase 2A-B55δ during mitosis. The protein kinase Greatwall (Gwl) phosphorylates α-endosulfine (Ensa), creating a potent inhibitor crucial for cell cycle control.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Entry into eukaryotic mitosis requires cyclin-dependent kinase 1 (Cdk1).
- Protein phosphatases oppose Cdk1 activity by regulating key kinases (Wee1, Myt1) and phosphatase Cdc25, and by antagonizing Cdk1's phosphorylation of downstream targets.
- Protein phosphatase 2A with a B55δ subunit (PP2A-B55δ) is a major phosphatase acting on CDK substrates and possesses antimitotic activity, with its activity inversely correlating to Cdk1 activity.
Purpose of the Study:
- To elucidate the mechanism by which PP2A-B55δ activity is inhibited during mitosis.
- To identify the regulatory factors controlling PP2A-B55δ function in the context of the cell cycle.
Main Methods:
- Utilized Xenopus egg extracts as a model system.
- Investigated the interaction between α-endosulfine (Ensa) and PP2A-B55δ.
- Examined the role of the protein kinase Greatwall (Gwl) in regulating Ensa activity.
Main Results:
- Identified α-endosulfine (Ensa) as a key regulator of PP2A-B55δ.
- Demonstrated that mitosis-specific phosphorylation of Ensa by Greatwall (Gwl) converts Ensa into a potent and specific inhibitor of PP2A-B55δ.
- Established an inverse relationship between PP2A-B55δ activity and Cdk1 activity, mediated by the Gwl-Ensa pathway.
Conclusions:
- Discovered a novel regulatory pathway involving Greatwall (Gwl) and α-endosulfine (Ensa) that inhibits protein phosphatase 2A-B55δ during mitosis.
- This pathway represents a previously unrecognized mechanism controlling mitotic entry and progression.
- The Gwl-Ensa-PP2A-B55δ axis provides new insights into the intricate regulation of the eukaryotic cell cycle.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Mitosis and Cytokinesis
The processes of the cell cycle occur over approximately 24 hours (in typical human cells) and in two major distinguishable stages. The...
Mitosis and Cytokinesis
The processes of the cell cycle occur over approximately 24 hours (in typical human cells) and in two major distinguishable stages. The...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

